Skip to content

CARDIO PREVENT

Active
Private limited companyfounded 20223 yrs activeKon. Elisabethlaan 11, 1700 Dilbeek, BelgiumKBO/BCE: BE 0791.933.239
Summary

The computed 12-month bankruptcy probability of CARDIO PREVENT is 2.5% (moderate). The 2025 annual accounts show equity of €3,698 and a net result of €161,198. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes · tick = 2024
Profitability100=
Solvency26▼-74
Growth58▼-20
Track record94
Bankruptcy probability, 12 months
2.5% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 3 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
1.1%
Return on assets
47.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-04-2026, 92 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
92 d early
2024
30 d late
2023
40 d early
2022
35 d early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 4 accounts on average 34 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 24 June (3 of the last 4 filed years within 55 days of that day).
Companies Code · seven months
Position in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 5 October 2022, CARDIO PREVENT was incorporated as a Private limited company.1 Total assets went from EUR 95,400 in 2022 to EUR 336,300 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2022 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€3,698▼ 98.8%
2024 · €318,641
Total assets
€336,300▼ 8.8%
2024 · €368,826
Net result
€161,198▼ 2.0%
2024 · €164,559
Working capital
-€118,058
2024 · €194,464
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line2022202320242025
Operating result€30,131-€167,682▲ 457%€212,178▲ 26.5%€210,240▼ 0.9%
Net result€22,376-€128,205▲ 473%€164,559▲ 28.4%€161,198▼ 2.0%
Equity€25,876-€154,081▲ 495%€318,641▲ 107%€3,698▼ 98.8%
Total assets€95,400-€219,351▲ 130%€368,826▲ 68.1%€336,300▼ 8.8%
Debt€69,524-€65,270▼ 6.1%€50,185▼ 23.1%€332,602▲ 563%
Working capital€7,802-€114,011▲ 1,361%€194,464▲ 70.6%-€118,058
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100,000€200,000Operating result 2022: €30,131€30,131Net result 2022: €22,376€22,376Operating result 2023: €167,682€167,682Net result 2023: €128,205€128,205Operating result 2024: €212,178€212,178Net result 2024: €164,559€164,559Operating result 2025: €210,240€210,240Net result 2025: €161,198€161,1982022202320242025€0€100,000€200,000Operating result 2023: €167,682€168,000Net result 2023: €128,205€128,000Operating result 2024: €212,178€212,000Net result 2024: €164,559€165,000Operating result 2025: €210,240€210,000Net result 2025: €161,198€161,000202320242025
The operating result falls in 2025; 2025 is 1% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €336,300
Fixed assets €134,377 ▼ 10.4%
Current assets €201,923 ▼ 7.7%
Equity and liabilities €336,300
Equity €3,698 ▼ 98.8%
Debt €332,602 ▲ 563%
Debt's share of the balance-sheet total rises from 13.6% to 98.9%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€235,062▲
2024 · €221,827
Cash flow
€186,019▲
2024 · €174,209
Current ratio
0.63▼
2024 · 8.96
Debt to equity
89.94▲
2024 · 0.16
ROA
47.9%▲
2024 · 44.6%
Interest coverage
137.56▲
2024 · 96.27
Debt ≤ 1 year
€319,981▲
2024 · €24,421
Debt > 1 year
€12,621▼
2024 · €25,764
Income taxes
€50,072▲
2024 · €47,363
A ratio outside any meaningful range has been withheld (balance sheet total €336,300, equity €3,698).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,155 companies that looked in July 2024 the way this one looks now, 2.6% went bankrupt within 24 months and 94% are still going.

  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
2.6% went bankrupt
2.6% stopped otherwise
94% still going

A further 0.7% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 2.5% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,155 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet Code20242025
Assets
Total assets20/58€368,826€336,300▼
Fixed assets21/28€149,941€134,377▼
Tangible fixed assets22/27€149,941€134,377▼
Land and buildings22€14,156€14,898▲
Plant, machinery and equipment23€10,315€8,400▼
Furniture and vehicles24€69,897€58,630▼
Leasing and similar rights25€55,574€52,449▼
Current assets29/58€218,885€201,923▼
Amounts receivable after more than one year29€85,000-
Other amounts receivable291€85,000-
Amounts receivable within one year40/41€11,595€11,523▼
Other amounts receivable41€11,595€11,523▼
Cash at bank and in hand54/58€111,055€185,175▲
Deferred charges and accrued income490/1€11,234€5,224▼
Equity and liabilities
Total equity and liabilities10/49€368,826€336,300▼
Equity10/15€318,641€3,698▼
Contributions10/11€3,500€3,500=
Profit (loss) carried forward14€315,141€198▼
Amounts payable17/49€50,185€332,602▲
Amounts payable after more than one year17€25,764€12,621▼
Financial debts170/4€25,764€12,621▼
Amounts payable within one year42/48€24,421€319,981▲
Current portion of amounts payable after more than one year42€12,521€13,143▲
Trade debts44€2,998€81▼
Suppliers440/4€2,998€81▼
Taxes, remuneration and social security45€4,500-
Taxes450/3€4,500-
Other amounts payable47/48€4,402€306,757▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9,649€24,821▲
Other operating charges640/8€626€556▼
Gross operating margin9900€222,453€235,618▲
Operating profit (loss)9901€212,178€210,240▼
Financial income75/76B€2,048€2,739▲
Recurring financial income75€2,048€2,739▲
Financial charges65/66B€2,304€1,709▼
Recurring financial charges65€2,304€1,709▼
Profit (loss) for the period before taxes9903€211,922€211,270▼
Income taxes67/77€47,363€50,072▲
Profit (loss) for the period9904€164,559€161,198▼
Profit (loss) for the period to be appropriated9905€164,559€161,198▼
Appropriation of the result
Profit (loss) to be appropriated9906€315,141€476,339▲
Profit (loss) brought forward from the previous period14P€150,581€315,141▲
Profit to be distributed694/7-€476,141
Return on contributions (dividend)694-€476,141

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,462€11,395€9,649€24,821▲ 157%
Other operating charges640/8€390€604€626€556▼ 11.1%
Gross operating margin9900€32,983€179,681€222,453€235,618▲ 5.9%
Operating profit (loss)9901€30,131€167,682€212,178€210,240▼ 0.9%
Financial income75/76B-€782€2,048€2,739▲ 33.7%
Recurring financial income75-€782€2,048€2,739▲ 33.7%
Financial charges65/66B€255€2,760€2,304€1,709▼ 25.8%
Recurring financial charges65€255€2,760€2,304€1,709▼ 25.8%
Profit (loss) for the period before taxes9903€29,876€165,705€211,922€211,270▼ 0.3%
Income taxes67/77€7,500€37,500€47,363€50,072▲ 5.7%
Profit (loss) for the period9904€22,376€128,205€164,559€161,198▼ 2.0%
Profit (loss) for the period to be appropriated9905€22,376€128,205€164,559€161,198▼ 2.0%
Line2022202320242025Change
Assets
Total assets20/58€95,400€219,351€368,826€336,300▼ 8.8%
Fixed assets21/28€68,288€87,754€149,941€134,377▼ 10.4%
Tangible fixed assets22/27€68,288€87,754€149,941€134,377▼ 10.4%
Land and buildings22-€13,657€14,156€14,898▲ 5.2%
Plant, machinery and equipment23-€13,076€10,315€8,400▼ 18.6%
Furniture and vehicles24-€2,322€69,897€58,630▼ 16.1%
Leasing and similar rights25€68,288€58,699€55,574€52,449▼ 5.6%
Current assets29/58€27,112€131,597€218,885€201,923▼ 7.7%
Amounts receivable after more than one year29-€65,000€85,000--
Other amounts receivable291-€65,000€85,000--
Amounts receivable within one year40/41-€7,500€11,595€11,523▼ 0.6%
Other amounts receivable41-€7,500€11,595€11,523▼ 0.6%
Cash at bank and in hand54/58€17,248€50,367€111,055€185,175▲ 66.7%
Deferred charges and accrued income490/1€9,864€8,730€11,234€5,224▼ 53.5%
Equity and liabilities
Total equity and liabilities10/49€95,400€219,351€368,826€336,300▼ 8.8%
Equity10/15€25,876€154,081€318,641€3,698▼ 98.8%
Contributions10/11€3,500€3,500€3,500€3,500=
Profit (loss) carried forward14€22,376€150,581€315,141€198▼ 99.9%
Amounts payable17/49€69,524€65,270€50,185€332,602▲ 563%
Amounts payable after more than one year17€50,214€38,286€25,764€12,621▼ 51.0%
Financial debts170/4€50,214€38,286€25,764€12,621▼ 51.0%
Amounts payable within one year42/48€19,310€17,586€24,421€319,981▲ 1,210%
Current portion of amounts payable after more than one year42€11,364€11,928€12,521€13,143▲ 5.0%
Trade debts44-€5,657€2,998€81▼ 97.3%
Suppliers440/4-€5,657€2,998€81▼ 97.3%
Taxes, remuneration and social security45--€4,500--
Taxes450/3--€4,500--
Other amounts payable47/48€7,947-€4,402€306,757▲ 6,869%
Accrued charges and deferred income492/3-€9,398---
Line2022202320242025Change
Profit (loss) for the period9904€22,376€128,205€164,559€161,198▼ 2.0%
+ Depreciation and write-downs630€2,462€11,395€9,649€24,821▲ 157%
Operating cash flow (approximation)€24,838€139,600€174,209€186,019▲ 6.8%
Investment in fixed assets (approximation)--€30,861-€71,836-€9,258▲ 87.1%
Change in cash-€33,119€60,688€74,120▲ 22.1%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-04
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
30-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 30 days late
2024
31-12
Financial Highest result since 2022net €164,559 ▲28.4%
Operating result €212,178, net result €164,559, both a record.
31-12
Financial Equity above €200,000Eq €318,641 ▲107%
3 profitable years in a row build equity to €318,641.
21-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Liquidity times 5current ratio 7.48
Current ratio from 1.40 to 7.48; short-term debt falls from €19,310 to €17,586.
31-12
Financial Equity above €150,000Eq €154,081 ▲495%
2 profitable years in a row build equity to €154,081.
26-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts

We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Dilbeek · 1 establishment unit since 2022
seat establishment The establishment unit on the map
Ground area
589 m²
Building footprint
373 m²
Volume, LiDAR
4,106 m³
2 parcels, Brussels, Flanders · tallest building 17.6 m, ±5 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
CARDIO PREVENT
Prins van Luiklaan 122, 1070 AnderlechtSpecialist medical practice
since 20222.336.770.283
2 parcels
Flanders 1 (50%) Brussels 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
23016D0297/00L000 Flanders 335 m² 1 · 149 m² 9.3 m · 2 fl.
21302A0045/00L005 Brussels 254 m² 1 · 224 m² 17.6 m · 5 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded05-10-2022
Fiscal year end31-12
Contact
E-mail martin.chaumont2012@gmail.com
E-invoicing
Reachable via Peppol
Peppol ID 0208:0791933239
Also 9925:BE0791933239
Registered 29-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.